ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Ganirelix
C80H113ClN18O13
1570.3 g/mol
APIDanger

Ganirelix

CAS124904-93-4
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Ganirelix acetate is a synthetic peptide compound that acts as a competitive antagonist of gonadotropin-releasing hormone (GnRH). It is primarily used as a pharmaceutical raw material in the manufacturing of injectable formulations for controlled ovarian stimulation in assisted reproduction protocols.

Pharmaceutical raw material for injectable gonadotropin-releasing hormone antagonist formulationsActive pharmaceutical ingredient used in assisted reproduction protocols

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Ganirelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Ganirelix acetate

CAS129311-55-3

pharmaceutical raw material

StrongSame Parent

Ganirelix

CAS123246-29-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Cetrorelix acetate

CAS130143-01-0

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Cetrorelix

CAS120287-85-6

pharmaceutical raw material

ApplicationSame Use

Abarelix

CAS183552-38-7

pharmaceutical raw material

ApplicationSame Use

Iturelix

CAS112568-12-4

pharmaceutical raw material

ApplicationSame Use

Elagolix sodium

CAS832720-36-2

pharmaceutical raw material

ApplicationSame Use

Linzagolix

CAS935283-04-8

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Danger
H360May damage fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure

Customs Tariff Classification

The international HS code for Ganirelix (CAS 124904-93-4) is 2937.19.

HS code (international, 6-digit)

2937.19

EU CN code (8-digit)

2937 19 00

Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.

Identifiers
IUPAC Name

(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methylpentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide

InChIKey

GJNXBNATEDXMAK-PFLSVRRQSA-N

SMILES

CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC

Synonyms (16)
  • Ganirelix (INN)
  • Ganirelixum [INN-Latin]
  • Antagon
  • Ganirelix
  • Ganirelixum
  • Orgalutran
  • Orgalutran (TN)

Sourcing Ganirelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→